Restricted accessCase reportFirst published online 2026-3
Postmortem Retinal Structural and Metabolic Analysis After Human Embryonic Stem Cell–Derived Retinal Pigment Epithelium Transplantation in a Patient With Stargardt Disease
Purpose: Stargardt disease is an inherited form of retinal degeneration characterized by early-onset central vision loss. This report describes the long-term retinal histologic characteristics of a patient with Stargardt disease after human embryonic stem cell–derived retinal pigment epithelium (hESC-RPE) transplantation. Methods: Eyes were obtained postmortem from an 80-year-old legally blind male patient with Stargardt disease. The patient had previously undergone hESC-RPE transplantation of his left eye, and the right eye (untransplanted) served as a control. Fluorescence lifetime imaging microscopy was used to study retinal structure and metabolic activity. Staining of the retina for lipofuscin was performed using the Armed Forces Institute of Pathology method. Results: Metabolic analysis showed that the macular area had more oxidative phosphorylation relative to the mid-peripheral retina, in both the transplanted and untransplanted eye. Melanin-laden RPE cells were detected in the transplanted eye, which correlated with a pigment band present on fundus images post–hESC-RPE transplantation. Conclusions: This case description illustrates the long-term survival of subretinal hESC-RPE cells post-transplantation in a patient with Stargardt disease.
SchwartzSDRegilloCDLamBL, et al. Human embryonic stem cell-derived retinal pigment epithelium in patients with age-related macular degeneration and Stargardt’s macular dystrophy: follow-up of two open-label phase 1/2 studies. Lancet. 2015;385(9967):509-516. doi:10.1016/S0140-6736(14)61376-3
2.
SchwartzSDHubschmanJPHeilwellG, et al. Embryonic stem cell trials for macular degeneration: a preliminary report. Lancet. 2012;379(9817):713-720. doi:10.1016/S0140-6736(12)60028-2
3.
SungYLeeMJChoiJ, et al. Long-term safety and tolerability of subretinal transplantation of embryonic stem cell-derived retinal pigment epithelium in Asian Stargardt disease patients. Br J Ophthalmol. 2021;105(6):829-837. doi:10.1136/bjophthalmol-2020-316225
4.
SongWKParkKMKimHJ, et al. Treatment of macular degeneration using embryonic stem cell-derived retinal pigment epithelium: preliminary results in Asian patients. Stem Cell Reports. 2015;4(5):860-872. doi:10.1016/j.stemcr.2015.04.005
5.
LiSLiuYWangL, et al. A phase I clinical trial of human embryonic stem cell-derived retinal pigment epithelial cells for early-stage Stargardt macular degeneration: 5-years’ follow-up. Cell Prolif. 2021;54(9):e13100. doi:10.1111/cpr.13100
6.
Brant FernandesRALojudiceFHZago RibeiroL, et al. Transplantation of subretinal stem cell–derived retinal pigment epithelium for Stargardt disease: a phase I clinical trial. Retina. 2023;43(2):263-274. doi:10.1097/IAE.0000000000003655
7.
MehatMSSundaramVRipamontiC, et al. Transplantation of human embryonic stem cell-derived retinal pigment epithelial cells in macular degeneration. Ophthalmology. 2018;125(11):1765-1775. doi:10.1016/j.ophtha.2018.04.037
8.
WeissJNLevyS.Stem Cell Ophthalmology Treatment Study (SCOTS): bone marrow-derived stem cells in the treatment of Stargardt disease. Medicines. 2021;8(2):10. doi:10.3390/medicines8020010
9.
OnerAGonenZBSevimDGSmim KahramanNUnluM.Suprachoroidal adipose tissue-derived mesenchymal stem cell implantation in patients with dry-type age-related macular degeneration and Stargardt’s macular dystrophy: 6-month follow-up results of a phase 2 study. Cellular Reprogram. 2018;20(6):329-336. doi:10.1089/cell.2018.0045
10.
KashaniAHLebkowskiJSHintonDR, et al. Survival of an HLA-mismatched, bioengineered RPE implant in dry age-related macular degeneration. Stem Cell Reports. 2022;17(3):448-458. doi:10.1016/j.stemcr.2022.01.001
11.
ShimSHKimGLeeDRLeeJEKwonHJSongWK.Survival of transplanted human embryonic stem cell–derived retinal pigment epithelial cells in a human recipient for 22 months. JAMA Ophthalmol. 2017;135(3):287. doi:10.1001/jamaophthalmol.2016.5824
12.
KesavamoorthyNJungeJAFraserSEAmeriH.Insights into metabolic activity and structure of the retina through multiphoton fluorescence lifetime imaging microscopy in mice. Cells. 2022;11(15):2265. doi:10.3390/cells11152265
13.
PalczewskaGBoguslawskiJStremplewskiP, et al. Noninvasive two-photon optical biopsy of retinal fluorophores. Proc Natl Acad Sci U S A. 2020;117(36):22532-22543. doi:10.1073/pnas.2007527117
14.
BoultonMDocchioFDayhaw-BarkerPRamponiRCubedduR.Age-related changes in the morphology, absorption and fluorescence of melanosomes and lipofuscin granules of the retinal pigment epithelium. Vision Res. 1990;30(9):1291-1303. doi:10.1016/0042-6989(90)90003-4
15.
TaubitzTTschulakowAVTikhonovichM, et al. Ultrastructural alterations in the retinal pigment epithelium and photoreceptors of a Stargardt patient and three Stargardt mouse models: indication for the central role of RPE melanin in oxidative stress. PeerJ. 2018;6:e5215. doi:10.7717/peerj.5215
16.
FangYTschulakowATaubitzT, et al. Fundus autofluorescence, spectral-domain optical coherence tomography, and histology correlations in a Stargardt disease mouse model. FASEB J. 2020;34(3):3693-3714. doi:10.1096/fj.201901784RR
17.
BonilhaVLRaybornMEBellBAMarinoMJFishmanGAHollyfieldJG.Retinal histopathology in eyes from a patient with Stargardt disease caused by compound heterozygous ABCA4 mutations. Ophthalmic Genet. 2016;37(2):150-160. doi:10.3109/13816810.2014.958861
18.
EagleRCLucierACBernardinoVBYanoffM.Retinal pigment epithelial abnormalities in fundus flavimmaculatus. Ophthalmology. 1980;87(12):1189-1200. doi:10.1016/S0161-6420(80)35106-3
19.
SteinmetzRLGarnerAMaguireJIBirdAC.Histopathology of incipient fundus flavimaculatus. Ophthalmology. 1991;98(6):953-956. doi:10.1016/S0161-6420(91)32197-3
20.
BirnbachCDJärveläínenMPossinDEMilamAH.Histopathology and immunocytochemistry of the neurosensory retina in fundus flavimaculatus. Ophthalmology. 1994;101(7):1211-1219. doi:10.1016/S0161-6420(13)31725-4
21.
LopezPFMaumeneeIHde la CruzZGreenWR.Autosomal-dominant fundus flavimaculatus. Ophthalmology. 1990;97(6):798-809. doi:10.1016/S0161-6420(90)32508-3
22.
EldredGELaskyMR.Retinal age pigments generated by self-assembling lysosomotropic detergents. Nature. 1993;361(6414):724-726. doi:10.1038/361724a0
23.
SkalaMCRichingKMGendron-FitzpatrickA, et al. In vivo multiphoton microscopy of NADH and FAD redox states, fluorescence lifetimes, and cellular morphology in precancerous epithelia. Proc Natl Acad Sci U S A. 2007;104(49):19494-19499. doi:10.1073/pnas.0708425104
24.
SkalaMCRichingKMBirdDK, et al. In vivo multiphoton fluorescence lifetime imaging of protein-bound and free nicotinamide adenine dinucleotide in normal and precancerous epithelia. J Biomed Opt. 2007;12(2):024014. doi:10.1117/1.2717503
25.
SameniSSyedAMarshJLDigmanMA.The phasor-FLIM fingerprints reveal shifts from OXPHOS to enhanced glycolysis in Huntington Disease. Sci Rep. 2016;6(1):34755. doi:10.1038/srep34755
26.
BrowneAWArnesanoCHarutyunyanN, et al. Structural and functional characterization of human stem-cell-derived retinal organoids by live imaging. Invest Ophthalmol Vis Sci. 2017;58(9):3311-3318. doi:10.1167/iovs.16-20796
27.
SuEKesavamoorthyNJungeJAZhengMCraftCMAmeriH.Comparison of retinal metabolic activity and structural development between rd10 mice and normal mice using multiphoton fluorescence lifetime imaging microscopy. Curr Issues Mol Biol. 2024;46(1):612-620. doi:10.3390/cimb46010039
28.
DysliCWolfSHatzKZinkernagelMS.Fluorescence lifetime imaging in Stargardt disease: potential marker for disease progression. Invest Ophthalmol Vis Sci. 2016;57(3):832. doi:10.1167/iovs.15-18033
29.
SolbergYDysliCEscherPBergerLWolfSZinkernagelMS.Retinal flecks in Stargardt disease reveal characteristic fluorescence lifetime transition over time. Retina. 2019;39(5):879-888. doi:10.1097/IAE.0000000000002519
30.
SolbergYDysliCEscherPBergerLWolfSZinkernagelMS.Fluorescence lifetime patterns of retinal pigment epithelium atrophy in patients with Stargardt disease and age-related macular degeneration. Ophthalmologica. 2020;243(3):195-206. doi:10.1159/000503567
31.
SwensonESGuestIIlicZ, et al. Hepatocyte nuclear factor-1 as marker of epithelial Phenotype reveals marrow-derived hepatocytes, but not duct cells, after liver injury in mice. Stem Cells. 2008;26(7):1768-1777. doi:10.1634/stemcells.2008-0148
32.
HrubanRHLongPPPerlmanEJ, et al. Fluorescence in situ hybridization for the Y-chromosome can be used to detect cells of recipient origin in allografted hearts following cardiac transplantation. Am J Pathol. 1993;142(4):975-980.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
